These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2975544

  • 1. Mechanism of action of sulphonylureas with special reference to the extrapancreatic effect: an overview.
    Beck-Nielsen H, Hother-Nielsen O, Pedersen O.
    Diabet Med; 1988 Oct; 5(7):613-20. PubMed ID: 2975544
    [No Abstract] [Full Text] [Related]

  • 2. Cardiovascular effects of sulphonylureas: role of K(ATP) channels.
    Howes LG.
    Diabetes Obes Metab; 2000 Apr; 2(2):67-73. PubMed ID: 11220526
    [No Abstract] [Full Text] [Related]

  • 3. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
    Poltorak VV, Gladkikh AI.
    Probl Endokrinol (Mosk); 1985 Apr; 31(2):76-85. PubMed ID: 2859589
    [No Abstract] [Full Text] [Related]

  • 4. Extrapancreatic effects of sulfonylurea drugs.
    Kaku K, Inoue Y, Kaneko T.
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S105-8. PubMed ID: 8529502
    [Abstract] [Full Text] [Related]

  • 5. [Primary and secondary failure of sulphonylureas].
    Kanno H, Sakura H.
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():719-23. PubMed ID: 12430308
    [No Abstract] [Full Text] [Related]

  • 6. Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part I--"The pros".
    Waldhäusl W.
    Horm Metab Res; 1996 Sep; 28(9):517-21. PubMed ID: 8911990
    [No Abstract] [Full Text] [Related]

  • 7. [Pathophysiology of diabetes mellitus type 2 and the mechanism of action and indications for using hypoglycemic sulfonylurea derivatives].
    Tatoń J, Koliński P.
    Pol Tyg Lek; 1985 May 06; 40(18):505-11. PubMed ID: 3892513
    [No Abstract] [Full Text] [Related]

  • 8. Does insulin preserve beta-cell function in type 2 diabetes?
    Heise T, Sawicki PT.
    J Intern Med; 2002 Apr 06; 251(4):283-5. PubMed ID: 11952878
    [No Abstract] [Full Text] [Related]

  • 9. Mechanism of insulin secretion and its modulation by sulfonylureas.
    Panten U.
    Contrib Nephrol; 1989 Apr 06; 73():16-21; discussion 22-3. PubMed ID: 2689091
    [No Abstract] [Full Text] [Related]

  • 10. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
    Pfeifer MA, Halter JB, Judzewitsch RG, Beard JC, Best JD, Ward WK, Porte D.
    Diabetes Care; 1984 Apr 06; 7 Suppl 1():25-34. PubMed ID: 6376026
    [Abstract] [Full Text] [Related]

  • 11. Do sulfonylureas influence hepatic insulin clearance?
    Groop LC, Groop PH, Stenman S, Saloranta C, Tötterman KJ, Fyhrquist F, Melander A.
    Diabetes Care; 1988 Sep 06; 11(8):689-90. PubMed ID: 3065007
    [No Abstract] [Full Text] [Related]

  • 12. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J, Haupt E, Cordes U, Kutschera J, Schöffling K.
    Horm Metab Res; 1973 Jan 06; 5(1):9-13. PubMed ID: 4196346
    [No Abstract] [Full Text] [Related]

  • 13. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE, Matthews DR.
    Horm Metab Res; 1996 Sep 06; 28(9):445-50. PubMed ID: 8911981
    [Abstract] [Full Text] [Related]

  • 14. Insulin release form isolated, human islets after acute or prolonged exposure to glimepiride.
    Del Guerra S, Parentini C, Bracci C, Lupi R, Marselli L, Aragona M, Navalesi R, Marchetti P.
    Acta Diabetol; 2000 Sep 06; 37(3):139-41. PubMed ID: 11277315
    [No Abstract] [Full Text] [Related]

  • 15. A 12-h intravenous insulin infusion restores the beta-cell response torpidity to sulfonylureas in patients affected by type 2 diabetes.
    Sinagra D, Greco D, Amato MC, D'Acquisto G, Galluzzo A.
    Diabetes Care; 2000 Dec 06; 23(12):1857-8. PubMed ID: 11128371
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical efficacy of glimepiride].
    Kaneko T, Sakamoto N.
    Nihon Rinsho; 1997 Nov 06; 55 Suppl():152-7. PubMed ID: 9434460
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Molecular mechanism of action of sulfonylureas].
    Ammon HP.
    Dtsch Med Wochenschr; 1988 May 27; 113(21):864-70. PubMed ID: 3286184
    [No Abstract] [Full Text] [Related]

  • 19. Cellular loci of sulfonylurea actions.
    Lebovitz HE.
    Diabetes Care; 1984 May 27; 7 Suppl 1():67-71. PubMed ID: 6376031
    [Abstract] [Full Text] [Related]

  • 20. [Progress in studies on antidiabetic agents].
    Tang L, Yang YS, Ji RY.
    Yao Xue Xue Bao; 2001 Sep 27; 36(9):711-5. PubMed ID: 12580115
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.